Cargando…

Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis

BACKGROUND AND AIM: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addition, we aim to establish a correlation between these variables and the severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kani, Ayse Sakalli, Ozercan, Ahmet, Kani, Haluk Tarik, Eren, Fatih, Sayar, Kemal, Yilmaz, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564252/
https://www.ncbi.nlm.nih.gov/pubmed/37822315
http://dx.doi.org/10.14744/hf.2023.2023.0034
_version_ 1785118470236536832
author Kani, Ayse Sakalli
Ozercan, Ahmet
Kani, Haluk Tarik
Eren, Fatih
Sayar, Kemal
Yilmaz, Yusuf
author_facet Kani, Ayse Sakalli
Ozercan, Ahmet
Kani, Haluk Tarik
Eren, Fatih
Sayar, Kemal
Yilmaz, Yusuf
author_sort Kani, Ayse Sakalli
collection PubMed
description BACKGROUND AND AIM: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addition, we aim to establish a correlation between these variables and the severity of the disease and fibrosis. MATERIALS AND METHODS: Patients who were following up with biopsy-proven metabolic dysfunction associated steatotic liver disease (MASLD) were included in the study. Histologically severe disease is characterized by a Steatosis, Activity, and Fibrosis activity score of ≥3 or the presence of advanced fibrosis (≥F3). Participants who met the inclusion criteria were given the Morningness and Evening Questionnaire (MEQ), the Pittsburgh Sleep Quality Index, and the Night Eating Questionnaire to complete. RESULTS: A total of 93 patients were included in this study. According to the MEQ, 48 patients were morning type (51.6%), and 42 (45.2%) were neither type. Sleep quality was determined to be inferior in the non-morningness group (p=0.002). A significantly higher proportion of patients with nocturnal eating syndrome had a non-morningness chronotype preference (n=22, 23.7%), compared to those with a morningness chronotype (n=9, 9.7%) (p=0.001). In the multivariate analysis, both age and poor sleep quality had significant impacts on advanced fibrosis, with odds ratios of 1.11 and 3.81, respectively. CONCLUSION: Despite the non-morningness chronotype demonstrating poorer sleep quality and a higher prevalence of night-eating behavior, our findings revealed no statistically significant differences in terms of sleep quality, nocturnal eating habits, or chronotype preferences among patients with varying degrees of MASLD severity. On the other hand, advanced fibrosis was significantly impacted by poor sleep quality.
format Online
Article
Text
id pubmed-10564252
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-105642522023-10-11 Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis Kani, Ayse Sakalli Ozercan, Ahmet Kani, Haluk Tarik Eren, Fatih Sayar, Kemal Yilmaz, Yusuf Hepatol Forum Research Article BACKGROUND AND AIM: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addition, we aim to establish a correlation between these variables and the severity of the disease and fibrosis. MATERIALS AND METHODS: Patients who were following up with biopsy-proven metabolic dysfunction associated steatotic liver disease (MASLD) were included in the study. Histologically severe disease is characterized by a Steatosis, Activity, and Fibrosis activity score of ≥3 or the presence of advanced fibrosis (≥F3). Participants who met the inclusion criteria were given the Morningness and Evening Questionnaire (MEQ), the Pittsburgh Sleep Quality Index, and the Night Eating Questionnaire to complete. RESULTS: A total of 93 patients were included in this study. According to the MEQ, 48 patients were morning type (51.6%), and 42 (45.2%) were neither type. Sleep quality was determined to be inferior in the non-morningness group (p=0.002). A significantly higher proportion of patients with nocturnal eating syndrome had a non-morningness chronotype preference (n=22, 23.7%), compared to those with a morningness chronotype (n=9, 9.7%) (p=0.001). In the multivariate analysis, both age and poor sleep quality had significant impacts on advanced fibrosis, with odds ratios of 1.11 and 3.81, respectively. CONCLUSION: Despite the non-morningness chronotype demonstrating poorer sleep quality and a higher prevalence of night-eating behavior, our findings revealed no statistically significant differences in terms of sleep quality, nocturnal eating habits, or chronotype preferences among patients with varying degrees of MASLD severity. On the other hand, advanced fibrosis was significantly impacted by poor sleep quality. Kare Publishing 2023-09-20 /pmc/articles/PMC10564252/ /pubmed/37822315 http://dx.doi.org/10.14744/hf.2023.2023.0034 Text en © Copyright 2023 by Hepatology Forum https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Kani, Ayse Sakalli
Ozercan, Ahmet
Kani, Haluk Tarik
Eren, Fatih
Sayar, Kemal
Yilmaz, Yusuf
Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title_full Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title_fullStr Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title_full_unstemmed Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title_short Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis
title_sort chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: assessing the relationship with disease severity and fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564252/
https://www.ncbi.nlm.nih.gov/pubmed/37822315
http://dx.doi.org/10.14744/hf.2023.2023.0034
work_keys_str_mv AT kaniaysesakalli chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis
AT ozercanahmet chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis
AT kanihaluktarik chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis
AT erenfatih chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis
AT sayarkemal chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis
AT yilmazyusuf chronotypepreferencesleepqualityandnighteatingbehaviorsinpatientswithmetabolicdysfunctionassociatedsteatoticliverdiseaseassessingtherelationshipwithdiseaseseverityandfibrosis